80 related articles for article (PubMed ID: 17975961)
1. FT-raman spectra of the border of infiltrating ductal carcinoma lesions.
de Miranda Marzullo AC; Neto OP; Bitar RA; da Silva Martinho H; Martin AA
Photomed Laser Surg; 2007 Oct; 25(5):455-60. PubMed ID: 17975961
[TBL] [Abstract][Full Text] [Related]
2. Raman spectroscopy of normal and diseased human breast tissues.
Frank CJ; McCreery RL; Redd DC
Anal Chem; 1995 Mar; 67(5):777-83. PubMed ID: 7762814
[TBL] [Abstract][Full Text] [Related]
3. [Study the Raman spectroscopy of breast tumor limbic tissue].
Zhao YL; Lü J; Ge XH; Yao SX; Liang EJ
Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Jul; 26(7):1267-71. PubMed ID: 17020037
[TBL] [Abstract][Full Text] [Related]
4. The lipid-reactive oxygen species phenotype of breast cancer. Raman spectroscopy and mapping, PCA and PLSDA for invasive ductal carcinoma and invasive lobular carcinoma. Molecular tumorigenic mechanisms beyond Warburg effect.
Surmacki J; Brozek-Pluska B; Kordek R; Abramczyk H
Analyst; 2015 Apr; 140(7):2121-33. PubMed ID: 25615557
[TBL] [Abstract][Full Text] [Related]
5. Novel chemometrics‑assisted spectroscopic methods for diagnosis and monitoring of invasive ductal carcinoma in breast tissue.
Albayrak M; Senol O; Demirkaya-Miloglu F; Calik M; Kadioglu Y
Bratisl Lek Listy; 2019; 120(3):184-187. PubMed ID: 31023035
[TBL] [Abstract][Full Text] [Related]
6. Resonance Raman and Raman spectroscopy for breast cancer detection.
Liu CH; Zhou Y; Sun Y; Li JY; Zhou LX; Boydston-White S; Masilamani V; Zhu K; Pu Y; Alfano RR
Technol Cancer Res Treat; 2013 Aug; 12(4):371-82. PubMed ID: 23448574
[TBL] [Abstract][Full Text] [Related]
7. Spectral morphometric characterization of breast carcinoma cells.
Barshack I; Kopolovic J; Malik Z; Rothmann C
Br J Cancer; 1999 Mar; 79(9-10):1613-9. PubMed ID: 10188915
[TBL] [Abstract][Full Text] [Related]
8. Mucinous lesions of the breast. A pathological continuum.
Weaver MG; Abdul-Karim FW; al-Kaisi N
Pathol Res Pract; 1993 Sep; 189(8):873-6. PubMed ID: 8302709
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of non-melanoma skin lesions from non-tumor human skin tissues in vivo using Raman spectroscopy and multivariate statistics.
Silveira FL; Pacheco MT; Bodanese B; Pasqualucci CA; Zângaro RA; Silveira L
Lasers Surg Med; 2015 Jan; 47(1):6-16. PubMed ID: 25583686
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
Yeung DK; Yang WT; Tse GM
Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004
[TBL] [Abstract][Full Text] [Related]
11. Raman spectroscopy for early detection of laryngeal malignancy: preliminary results.
Stone N; Stavroulaki P; Kendall C; Birchall M; Barr H
Laryngoscope; 2000 Oct; 110(10 Pt 1):1756-63. PubMed ID: 11037840
[TBL] [Abstract][Full Text] [Related]
12. Mucinous metaplasia of breast carcinoma with macrocystic transformation resembling ovarian mucinous cystadenocarcinoma in a case of synchronous bilateral infiltrating ductal carcinoma.
Lee SH; Chaung CR
Pathol Int; 2008 Sep; 58(9):601-5. PubMed ID: 18801076
[TBL] [Abstract][Full Text] [Related]
13. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
14. Studying the pathological and biochemical features in breast cancer progression by confocal Raman microspectral imaging of excised tissue samples.
Wang S; Li H; Ren Y; Yu F; Song D; Zhu L; Yu S; Jiang S; Zeng H
J Photochem Photobiol B; 2021 Sep; 222():112280. PubMed ID: 34375907
[TBL] [Abstract][Full Text] [Related]
15. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
16. SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma.
Hsiao YH; Lien HC; Hwa HL; Kuo WH; Chang KJ; Hsieh FJ
Breast J; 2010; 16(3):305-8. PubMed ID: 20210803
[TBL] [Abstract][Full Text] [Related]
17. [Expression of alpha-tubulin and gamma-tubulin in premalignant lesion and carcinoma of breast and the significance thereof].
Niu Y; Wang Y; Yu Y; Ding XM; Lü SH; Xiao XQ
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):56-60. PubMed ID: 16606540
[TBL] [Abstract][Full Text] [Related]
18. Exploring type II microcalcifications in benign and premalignant breast lesions by shell-isolated nanoparticle-enhanced Raman spectroscopy (SHINERS).
Liang L; Zheng C; Zhang H; Xu S; Zhang Z; Hu C; Bi L; Fan Z; Han B; Xu W
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Nov; 132():397-402. PubMed ID: 24887501
[TBL] [Abstract][Full Text] [Related]
19. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
20. Biochemical correlation of Raman spectra of normal, benign and malignant breast tissues: a spectral deconvolution study.
Chowdary MV; Kalyan Kumar K; Mathew S; Rao L; Krishna CM; Kurien J
Biopolymers; 2009 Jul; 91(7):539-46. PubMed ID: 19226625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
